Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors.

MLA

Decker, Thomas, et al. “Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors.” Oncology Research & Treatment, vol. 45, no. 5, May 2022, pp. 248–53. EBSCOhost, https://doi.org/10.1159/000523758.

APA

Decker, T., Bichler, M., Birtel, A., Fischer, G., Geiger, K., Gaenger, S., Nonnenbroich, C., Dechow, T., & Muendlein, A. (2022). Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors. Oncology Research & Treatment, 45(5), 248–253. https://doi.org/10.1159/000523758

Chicago

Decker, Thomas, Matthias Bichler, Andrea Birtel, Gerhard Fischer, Kathrin Geiger, Stella Gaenger, Christoph Nonnenbroich, Tobias Dechow, and Axel Muendlein. 2022. “Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors.” Oncology Research & Treatment 45 (5): 248–53. doi:10.1159/000523758.